Deciphera shares skyrocket as cancer drug improves progression-free survival
Deciphera Pharmaceuticals Inc's shares more than doubled on Tuesday after the drugmaker said its treatment helped stomach cancer patients live longer without their disease worsening in a late-stage study. Reuters Health News
In Charge of Animal Disease Study, and Surveillance Bureau, expert on Disease Study, Surveillance, Early Warning/Response, Client Training, and Development. Executive Officer for projects avoiding spread of diseases. Works at Iran Veterinary Organization; Veterinarian, 2000 - present.